Another study involving 467 individuals with lung cancer undergoing chemotherapy found that an SNP in lncRNA ANRIL was associated with a lower incidence of overall toxicity (grades 3–4) (p = 0.028). This evidence concerns the gene CDKN2B-AS1 and lung cancer.